Showing results (401-410 of 461) with videos related to
Sort By:
Pageof 47
Japanese Journal of Clinical Oncology|August 13, 2013
Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trialKeisuke Uehara, Kazuhiro Hiramatsu, Atsuyuki Maeda, et al.Oncology Letters|September 23, 2020
MZB1 expression indicates poor prognosis in estrogen receptor-positive breast cancerManabu Watanabe, Masahiro Shibata, Takahiro Inaishi, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 15, 2020
Indications for neoadjuvant treatment based on risk factors for poor prognosis before and after neoadjuvant chemotherapy alone in patients with locally advanced rectal cancerAtsushi Ogura, Kay Uehara, Toshisada Aiba, et al.Nagoya Journal of Medical Science|April 11, 2020
A prospective trial to evaluate treatment effects of a β-hydroxy-β-methylbutyrate containing nutrient for leakage at the anastomotic site after esophagectomyMitsuro Kanda, Masahiko Koike, Masahide Fukaya, et al.International Journal of Oncology|January 1, 2010
Forkhead box A1 transcriptional pathway in KRT7-expressing esophageal squamous cell carcinomas with extensive lymph node metastasisMasayuki Sano, Kazuhiko Aoyagi, Hiro Takahashi, et al.The American Journal of Pathology|February 17, 2009
Cyclooxygenase-2 is involved in the up-regulation of matrix metalloproteinase-9 in cholangiocarcinoma induced by tumor necrosis factor-alphaKeita Itatsu, Motoko Sasaki, Junpei Yamaguchi, et al.Journal of Hepato-Biliary-Pancreatic Surgery|November 5, 2003
Intrahepatic segmental bile duct patterns in hepatolithiasis: a comparative cholangiographic study between Taiwan and JapanYuichi Kitagawa, Yuji Nimura, Naokazu Hayakawa, et al.Journal of Gastroenterology|July 1, 2016
Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter studyJunichi Shoda, Atsushi Matsuda, Takashi Shida, et al.Journal of Proteomics|December 14, 2011
Macrophage-capping protein as a tissue biomarker for prediction of response to gemcitabine treatment and prognosis in cholangiocarcinomaNoriaki Morofuji, Hidenori Ojima, Hiroaki Onaya, et al.Anticancer Research|June 26, 2024
TLK1 Inhibition Enhances the Anticancer Effect of Deep UV Irradiation Through CHK1 ActivationYoshio Koike, Toshio Kokuryo, Junpei Yamaguchi, et al.Pageof 47